The Latest Headlines at American Banking and Market News
Apple Inc. (NASDAQ:AAPL) Stock Holdings Lowered by Mycio Wealth Partners LLC
Mycio Wealth Partners LLC reduced its position in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 7.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange... More of this article »
SFE Investment Counsel Reduces Stock Position in Apple Inc. (NASDAQ:AAPL)
SFE Investment Counsel lowered its position in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 1.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 84,931 shares of the iPhone maker’s... More of this article »
Apple Inc. (NASDAQ:AAPL) Shares Acquired by Asset Management One Co. Ltd.
Asset Management One Co. Ltd. increased its position in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 4.5% during the 4th quarter, HoldingsChannel reports. The fund owned 6,184,360 shares of the iPhone maker’s stock... More of this article »
Kickstand Ventures LLC. Sells 187 Shares of Apple Inc. (NASDAQ:AAPL)
Kickstand Ventures LLC. reduced its position in Apple Inc. (NASDAQ:AAPL – Free Report) by 8.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The... More of this article »
Susquehanna Cuts Boyd Gaming (NYSE:BYD) Price Target to $75.00
Boyd Gaming (NYSE:BYD – Get Free Report) had its price objective dropped by research analysts at Susquehanna from $77.00 to $75.00 in a research note issued on Wednesday, Marketbeat Ratings reports. The firm presently has a... More of this article »
Piper Sandler Reiterates Overweight Rating for Citigroup (NYSE:C)
Citigroup (NYSE:C – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Piper Sandler in a research note issued on Wednesday,Benzinga reports. They presently have a $77.00... More of this article »
Can-Fite BioPharma (NYSE:CANF) Receives “Buy” Rating from D. Boral Capital
D. Boral Capital reissued their buy rating on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report report published on Tuesday morning,Benzinga reports. D. Boral Capital currently has a $10.00 price target... More of this article »
Can-Fite BioPharma (NYSE:CANF) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a report issued on Wednesday. The firm set a “sell” rating on the stock. Separately, D. Boral Capital reissued a “buy”... More of this article »
Stifel Nicolaus Cuts Civeo (NYSE:CVEO) Price Target to $28.00
Civeo (NYSE:CVEO – Free Report) had its price target decreased by Stifel Nicolaus from $30.00 to $28.00 in a research report released on Tuesday, Marketbeat Ratings reports. Stifel Nicolaus currently has a buy rating on the business... More of this article »
DuPont de Nemours (NYSE:DD) Price Target Lowered to $80.00 at Mizuho
DuPont de Nemours (NYSE:DD – Free Report) had its price objective lowered by Mizuho from $100.00 to $80.00 in a research report report published on Tuesday morning,Benzinga reports. Mizuho currently has an outperform rating on... More of this article »
Chatham Lodging Trust (NYSE:CLDT) Given New $9.50 Price Target at Stifel Nicolaus
Chatham Lodging Trust (NYSE:CLDT – Get Free Report) had its price target reduced by equities researchers at Stifel Nicolaus from $11.00 to $9.50 in a research note issued to investors on Wednesday,Benzinga reports. The firm... More of this article »
Chevron (NYSE:CVX) Earns Neutral Rating from BNP Paribas
BNP Paribas reaffirmed their neutral rating on shares of Chevron (NYSE:CVX – Free Report) in a research report report published on Tuesday morning, MarketBeat reports. They currently have a $140.00 price objective on the oil... More of this article »
CEMEX (NYSE:CX) Upgraded by StockNews.com to “Buy” Rating
CEMEX (NYSE:CX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Wednesday. Several other equities research analysts have also recently... More of this article »